Key result
Mitral valve replacement in severe pulmonary hypertension shows ~93% 2-year survival and functional improvements.
Why the study?
The study was conducted to assess the clinical, echocardiographic, and hemodynamic changes occurring in patients with severe pulmonary hypertension after mitral valve replacement in the early and mid-term period.
Does mitral valve replacement improve clinical, echocardiographic, and hemodynamic outcomes in patients with mitral valve disease and severe pulmonary hypertension?
Population
40 patients undergoing mitral valve replacement for mitral valve disease with severe PH (> 50 mmHg)
Design
Prospective cohort study
Follow-up
2 years
Authors
Loading...
Supports mitral valve replacement in severe pulmonary hypertension; hypothesis-generating and requires randomized confirmation before practice change.
Cohort (n=40)
No
Does mitral valve replacement improve clinical, echocardiographic, and hemodynamic outcomes in patients with mitral valve disease and severe pulmonary hypertension?
Mitral valve replacement is safe and effective in patients with severe pulmonary hypertension, yielding significant functional and hemodynamic improvements at 2 years.
Ali et al. (2021) conducted a cohort in Mitral valve disease with severe pulmonary hypertension (n=40). Mitral valve replacement was evaluated on Survival at two years. Mitral valve replacement in patients with severe pulmonary hypertension was safe and effective, yielding a 2-year survival rate of 92.5% alongside significant functional improvements.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: